Joel A Sincavage

Array ( [id] => 5656490 [patent_doc_number] => 20060142226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'RNA interference mediated inhibition of cholesteryl ester transfer protein (CETP) gene expression using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 10/921554 [patent_app_country] => US [patent_app_date] => 2004-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 61494 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142226.pdf [firstpage_image] =>[orig_patent_app_number] => 10921554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859807 [patent_doc_number] => 20060229266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Silencing of tgf-beta receptor type II expression by sirna' [patent_app_type] => utility [patent_app_number] => 10/567958 [patent_app_country] => US [patent_app_date] => 2004-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12553 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229266.pdf [firstpage_image] =>[orig_patent_app_number] => 10567958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5041155 [patent_doc_number] => 20070093437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Rna interference mediated inhibition of xiap gene expression using short interfering nucleic acid (sina)' [patent_app_type] => utility [patent_app_number] => 10/567888 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 65591 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20070093437.pdf [firstpage_image] =>[orig_patent_app_number] => 10567888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7251648 [patent_doc_number] => 20040259079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Substantially complete ribozyme libraries' [patent_app_type] => new [patent_app_number] => 10/898106 [patent_app_country] => US [patent_app_date] => 2004-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 50772 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259079.pdf [firstpage_image] =>[orig_patent_app_number] => 10898106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112626 [patent_doc_number] => 07713924 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'Methods for treating conditions associated with the accumulation of excess extracellular matrix' [patent_app_type] => utility [patent_app_number] => 10/887378 [patent_app_country] => US [patent_app_date] => 2004-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 22 [patent_no_of_words] => 14189 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713924.pdf [firstpage_image] =>[orig_patent_app_number] => 10887378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918726 [patent_doc_number] => 20050096287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Compositions and methods for topical delivery of oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/876962 [patent_app_country] => US [patent_app_date] => 2004-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21881 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096287.pdf [firstpage_image] =>[orig_patent_app_number] => 10876962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7038846 [patent_doc_number] => 20050158280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Method of reducing angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/870388 [patent_app_country] => US [patent_app_date] => 2004-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 30679 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158280.pdf [firstpage_image] =>[orig_patent_app_number] => 10870388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 296074 [patent_doc_number] => 07541344 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-02 [patent_title] => 'Modulation of survivin expression' [patent_app_type] => utility [patent_app_number] => 10/559636 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38525 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/541/07541344.pdf [firstpage_image] =>[orig_patent_app_number] => 10559636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7202672 [patent_doc_number] => 20050042647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Phosphorous-linked oligomeric compounds and their use in gene modulation' [patent_app_type] => utility [patent_app_number] => 10/860455 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 38304 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042647.pdf [firstpage_image] =>[orig_patent_app_number] => 10860455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 800401 [patent_doc_number] => 07425545 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-16 [patent_title] => 'Modulation of C-reactive protein expression' [patent_app_type] => utility [patent_app_number] => 10/858500 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49333 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/425/07425545.pdf [firstpage_image] =>[orig_patent_app_number] => 10858500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4471180 [patent_doc_number] => 07943754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'Bioinformatically detectable group of novel regulatory bacterial and bacterial associated oligonucleotides and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/709691 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 37 [patent_no_of_words] => 69905 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943754.pdf [firstpage_image] =>[orig_patent_app_number] => 10709691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075263 [patent_doc_number] => 20050148531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Modulation of gene expression using DNA-DNA hybrids' [patent_app_type] => utility [patent_app_number] => 10/847204 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7975 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148531.pdf [firstpage_image] =>[orig_patent_app_number] => 10847204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5672972 [patent_doc_number] => 20060178327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Inhibition of gene expression by delivery of specially selected double stranded or other forms of small interfering RNA precursors enabling the formation and function of small interfering RNA in vivo and in vitro' [patent_app_type] => utility [patent_app_number] => 10/844527 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4736 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178327.pdf [firstpage_image] =>[orig_patent_app_number] => 10844527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7084019 [patent_doc_number] => 20050049399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Novel molecules of the card-related protein family and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/843188 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 53853 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049399.pdf [firstpage_image] =>[orig_patent_app_number] => 10843188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4496142 [patent_doc_number] => 07947657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Method for selective inhibition of human N-myc gene in N-myc expressing tumors through antisense and antigen peptido-nucleic acids (PNA)' [patent_app_type] => utility [patent_app_number] => 10/554291 [patent_app_country] => US [patent_app_date] => 2004-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4423 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947657.pdf [firstpage_image] =>[orig_patent_app_number] => 10554291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7346758 [patent_doc_number] => 20040192633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Antisense modulation of short heterodimer partner-1 expression' [patent_app_type] => new [patent_app_number] => 10/835208 [patent_app_country] => US [patent_app_date] => 2004-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25874 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192633.pdf [firstpage_image] =>[orig_patent_app_number] => 10835208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7329848 [patent_doc_number] => 20040254133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Antisense modulation of interferon gamma receptor 1 expression' [patent_app_type] => new [patent_app_number] => 10/476022 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25463 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254133.pdf [firstpage_image] =>[orig_patent_app_number] => 10476022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7161240 [patent_doc_number] => 20050084876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Flip genes and flip proteins' [patent_app_type] => utility [patent_app_number] => 10/832218 [patent_app_country] => US [patent_app_date] => 2004-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 22405 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20050084876.pdf [firstpage_image] =>[orig_patent_app_number] => 10832218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089064 [patent_doc_number] => 20050009177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Telomerase interference' [patent_app_type] => utility [patent_app_number] => 10/831267 [patent_app_country] => US [patent_app_date] => 2004-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8816 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009177.pdf [firstpage_image] =>[orig_patent_app_number] => 10831267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7466182 [patent_doc_number] => 20040198679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Use of inhibitors of expression or activity of p8/com1 for treating tumors' [patent_app_type] => new [patent_app_number] => 10/482661 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3373 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198679.pdf [firstpage_image] =>[orig_patent_app_number] => 10482661 [rel_patent_id] =>[rel_patent_doc_number] =>)